A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Cited by (1,002)

Items 401–500 of 1,002

1. Depressive disorders are associated with increased peripheral blood cell deformability: a cross-sectional case-control study (Mood-Morph)
   Andreas Walther, Anne Mackens-Kiani, Julian Eder, Maik Herbig, C. Herold, Clemens Kirschbaum, Jochen R. Guck, Lucas Daniel Wittwer, Katja Beesdo‐Baum, Martin Kräter · 2022 · Translational Psychiatry
2. Sex differences in the association between serum α-Klotho and depression in middle-aged and elderly individuals: A cross-sectional study from NHANES 2007–2016
   Yi Zhang, Jieyi Lu, Shicun Huang, Yuan Chen, Qi Fang, Yin Cao · 2023 · Journal of Affective Disorders
3. Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes
   Frederike Stein, Tina Meller, Katharina Brosch, Simon Schmitt, Kai G. Ringwald, Julia‐Katharina Pfarr, Susanne L. Meinert, Katharina Thiel, Hannah Lemke, Lena Waltemate et al. · 2021 · Schizophrenia Bulletin
4. Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies
   Emanuele Felice Osimo, Luke Baxter, Jan Štochl, Benjamin Ian Perry, Stephen A. Metcalf, Setor Kwadzo Kunutsor, Jari Antero Laukkanen, Marie Kim Wium‐Andersen, Peter Brian Jones, Golam Mohammed Khandaker · 2021 · Schizophrenia
5. The Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior
   Gianluca Serafini, Alessandra Costanza, Andrea Aguglia, Andrea Amerio, Alice Trabucco, Andrea Escelsior, Leo Sher, Mario Amore · 2022 · Medical Clinics of North America
6. Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study
   Luca Sforzini, Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, Nicole Mariani, Daniela Enache, Caitlín N. M. Hastings, Giulia Lombardo, Maria Antonietta Nettis, Naghmeh Nikkheslat et al. · 2023 · Translational Psychiatry
7. Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation
   Mario Pinzi, Andrea M. Fagiolini, Despoina Koukouna, Giacomo Gualtieri, Maria Beatrice Rescalli, Caterina Pierini, Simone Pardossi, Benjamin Patrizio, Alessandro Cuomo · 2025 · Cells
8. The role of PON-1, GR, IL-18, and OxLDL in depression with and without posttraumatic stress disorder
   Ewa Alicja Ogłodek · 2017 · Pharmacological Reports
9. Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples
   Sarah Cohen‐Woods, Helen Louise Fisher, Diana Ahmetspahic, Konstantinos Douroudis, David Stacey, Georgina Mayling Hosang, Ania Korszun, M J Owen, Nick J. Craddock, Volkert Arolt et al. · 2017 · Brain Behavior and Immunity
10. Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis
    Błażej Misiak, Francesco Bartoli, Filip Stramecki, Jerzy Samochowiec, Michał Lis, Justyna Kasznia, Konrad Jarosz, Bartłomiej Stańczykiewicz · 2019 · Neuroscience & Biobehavioral Reviews
11. Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort
    So Young Kim, Chanyang Min, Dong Jun Oh, Hyo Geun Choi · 2019 · Lara D. Veeken
12. Differences in cytokines between patients with generalised anxiety disorder and panic disorder
    Zhili Zou, Bo Zhou, Yulan Huang, Jinyu Wang, Wenjiao Min, Tao Li · 2020 · Journal of Psychosomatic Research
13. Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia
    Frederike Stein, Gunnar Lemmer, Simon Schmitt, Katharina Brosch, Tina Meller, Elena Fischer, Cynthia A. Kraus, Lutz Lenhard, Birgit Köhnlein, Harumi Murata et al. · 2020 · Schizophrenia Research
14. Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17‐like cells in multiple sclerosis patients with major depression
    Marisa C. Sales, Taissa M. Kasahara, Priscila M. Sacramento, Átila Duque Rossi, Marcos Octávio S.D. Cafasso, Hugo A. A. Oyamada, Joana Hygino, Fabianna Alvim, Regis Mariano de Andrade, Cláudia Cristina Ferreira Vasconcelos et al. · 2020 · Immunology
15. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
    Matej Ľupták, Danica Michaličková, Zdeněk Fišar, Eva Kitzlerová, Jana Hroudová · 2021 · World Journal of Psychiatry
16. Baicalein Exerts Therapeutic Effects against Endotoxin-Induced Depression-like Behavior in Mice by Decreasing Inflammatory Cytokines and Increasing Brain-Derived Neurotrophic Factor Levels
    Hsin‐Tzu Liu, Yu‐Ning Lin, Ming-Cheng Tsai, Ya‐Chi Wu, Ming-Chung Lee · 2022 · Antioxidants
17. Beneficial impact of intracerebroventricular fractalkine administration on behavioral and biochemical changes induced by prenatal stress in adult rats: Possible role of NLRP3 inflammasome pathway
    Joanna Ślusarczyk, Ewa Trojan, Karolina Wydra, Katarzyna Głombik, Katarzyna Chamera, Mateusz Wojciech Kucharczyk, Bogusława Budziszewska, Marta Kubera, Władysław Lasoń, Małgorzata Filip et al. · 2016 · Biochemical Pharmacology
18. Overlapping evidence of innate immune dysfunction in psychotic and affective disorders
    Hughes, H.K., Ashwood, P. · 2020 · Brain, Behavior, & Immunity - Health
19. Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
    Daniella Dwir, Inès Khadimallah, Lijing Xin, Meredith Rahman, Fei Du, Döst Öngür, Kim Q. · 2023 · The International Journal of Neuropsychopharmacology
20. A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression
    Éimear M. Foley, Chloe Slaney, Nicholas A Donnelly, Muzaffer Kaşer, Louise Ziegler, Golam Mohammed Khandaker · 2024 · Psychoneuroendocrinology
21. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation
    Buranee Kanchanatawan, Sunee Sirivichayakul, Kiat Ruxrungtham, Andre Ferrer Carvalho, M. Geffard, George Anderson, Michael H. J. Maes · 2017 · Molecular Neurobiology
22. Differential gene expression analysis in blood of first episode psychosis patients
    Daniel J. Leirer, Conrad Osamede Iyegbe, Marta Di Forti, Hamel Patel, Elena Carra, Sara Fraietta, Marco Colizzi, Valeria Mondelli, Diego Quattrone, John Lally et al. · 2019 · Schizophrenia Research
23. Treatment failure in inflammatory arthritis: time to think about syndemics?
    Elena Nikiphorou, Heidi K Lempp, Brandon A. Kohrt · 2019 · Rheumatology
24. Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders
    Emanuela Balestrieri, Claudia Matteucci, Chiara Cipriani, Sandro Grelli, Laura Ricceri, Gemma Calamandrei, Paola Sinibaldi Vallebona · 2019 · International Journal of Molecular Sciences
25. Peripheral inflammation is associated with dysfunctional corticostriatal circuitry and executive dysfunction in bipolar disorder patients
    Huai‐Hsuan Tseng, Hui Hua Chang, Shyh‐Yuh Wei, Tsung‐Hua Lu, Yi-Ting Hsieh, Yen Kuang Yang, Po See Chen · 2020 · Brain Behavior and Immunity
26. Infections, inflammation, and risk of neuropsychiatric disorders: the neglected role of “co-infection”
    Amir Abdoli, Ali Taghipour, Majid Pirestani, Mirza Ali Mofazzal Jahromi, Abazar Roustazadeh, Hamed Mir, Hoda Mirzaian Ardakani, Azra Kenarkoohi, Shahab Falahi, Mahdi Karimi · 2020 · Heliyon
27. Beta-adrenergic blockade blunts inflammatory and antiviral/antibody gene expression responses to acute psychosocial stress
    Jennifer K. MacCormack, Monica M. Gaudier‐Diaz, Emma Armstrong‐Carter, Jesusa M.G. Arevalo, Samantha E Meltzer-Brody, Erica K. Sloan, Steve W. Cole, Keely A. Muscatell · 2021 · Neuropsychopharmacology
28. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
    Nuray Çakici, Arjen L. Sutterland, Brenda W.J.H. Penninx, Lieuwe de Haan, Nico J.M. van Beveren · 2021 · Psychological Medicine
29. Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases
    Caitlin E. Murphy, Adam K. Walker, Maryanne O׳Donnell, Cherrie Ann Galletly, Andrew R. Lloyd, Dennis Liu, Cynthia Shannon Weickert, Thomas Wesley Weickert · 2022 · Translational Psychiatry
30. Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia
    Natalia Alekseevna Shnayder, Aiperi K. Khasanova, Anna Strelnik, Mustafa Al-Zamil, Andrey Otmakhov, Н. Г. Незнанов, German Alexandrovich Shipulin, Марина Михайловна Петрова, Natalia P. Garganeeva, Regina Faritovna Nasyrova · 2022 · International Journal of Molecular Sciences
31. Clinical Staging for Youth Mental Disorders: Progress in Reforming Diagnosis and Clinical Care
    McGorry, Patrick D., Mei, Cristina · 2021 · Annual Review of Developmental Psychology
32. Exaggerated amygdala response to threat and association with immune hyperactivity in depression
    Sarah C. Boukezzi, Sara Costi, Lisa M. Shin, Seunghee Kim‐Schulze, Flurin Cathomas, Abigail B. Collins, Scott J. Russo, Laurel S. Morris, James W. Murrough · 2022 · Brain Behavior and Immunity
33. Major depressive disorder: Biomarkers and biosensors
    Masoomeh Dadkhah, Mohsen Jafarzadehgharehziaaddin, Soheila Molaei, Morteza Akbari, Negin Gholizadeh, Farzaneh Fathi · 2023 · Clinica Chimica Acta
34. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches
    Abigail Raffner Basson, Minh C. Lam, Fabio Cominelli · 2017 · Gastroenterology Clinics of North America
35. The impact of inflammation on neurocognition and risk for psychosis: a critical review
    Sophia Kogan, Luz H. Ospina, Vijay Anand Mittal, David Kimhy · 2019 · European Archives of Psychiatry and Clinical Neuroscience
36. Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue
    Ryo Aoki, Nobuyuki Kobayashi, Go Suzuki, Hirohiko Kuratsune, Kazuya Shimada, Naomi Oka, Mayumi M. Takahashi, Wataru Yamadera, Masayuki Iwashita, Shinichi Tokuno et al. · 2016 · Biochemical and Biophysical Research Communications
37. Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry
    David S. Thylur, David R. Goldsmith · 2022 · Harvard Review of Psychiatry
38. (Re)building the nervous system: A review of neuron–glia interactions from development to disease
    Matthew D. Demmings, Luana da Silva Chagas, Marianela Evelyn Traetta, Rui S. Rodrigues, María Florencia Acutain, Evgeny P. Barykin, Ashok Kumar Datusalia, Liliana German‐Castelan, Vanesa Soledad Mattera, Pedzisai Mazengenya et al. · 2024 · Journal of Neurochemistry
39. Dietary Inflammatory Potential and the Risk of Incident Depression in Adults: A Systematic Review
    Sorayya Kheirouri, Mohammad Alizadeh · 2018 · Advances in Nutrition
40. Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
    Nuray Çakici, Mariska Bot, Femke Lamers, Thomas Janssen, Peter J. van der Spek, Lieuwe de Haan, Sabine Bahn, Brenda W.J.H. Penninx, Nico J.M. van Beveren · 2019 · European Neuropsychopharmacology
41. Adjunctive minocycline for major mental disorders: A systematic review
    Wei Zheng, Xiaomin Zhu, Qinge Zhang, Gen Cheng, Dong-Bin Cai, Jie He, Chee H. Ng, Gabor Sandor Ungvari, Xiao-Jiang Peng, Yuping Ning et al. · 2019 · Journal of Psychopharmacology
42. Rates of hepatitis B and C in patients with schizophrenia: A meta-analysis
    Emily Lluch, Brian J. Miller · 2019 · General Hospital Psychiatry
43. Analysis of cytokine levels, T regulatory cells and serotonin content in patients with depression
    Jasmin Obermanns, Elena Krawczyk, Georg Juckel, Barbara Emons · 2021 · European Journal of Neuroscience
44. Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
    Yoo Jin Jung, David Tweedie, Michael T. Scerba, Dong Seok Kim, Maria Francesca Palmas, Augusta Pisanu, Anna Rosa Carta, Nigel H. Greig · 2021 · Frontiers in Neuroscience
45. Inflammatory cytokines in and cognitive function of adolescents with first-episode schizophrenia, bipolar disorder, or major depressive disorder
    Mu‐Hong Chen, Ju-Wei Hsu, Kai‐Lin Huang, Shih‐Jen Tsai, Pei‐Chi Tu, Ya‐Mei Bai · 2021 · CNS Spectrums
46. Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
    Chen Lin, Ke Chen, Jianjin Yu, Wei Feng, Weihong Fu, Fude Yang, Xiangyang Zhang, Dachun Chen · 2021 · BMC Psychiatry
47. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study
    Sudhir Karthikeyan, Mikaela K. Dimick, Lisa Fıksenbaum, Hyunjin Jeong, Boris B. Birmaher, James L. Kennedy, Krista L. Lanctôt, ANTHONY J. LEVITT, Gregory E. Miller, Ayal Schaffer et al. · 2021 · Brain Behavior and Immunity
48. Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
    Taotao Zhou, Jijia Sun, Li-dong Tang, Ying Yuan, Jianying Wang, Lei Zhang · 2023 · Frontiers in Immunology
49. Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis
    Md. Rabiul Islam, Md. Sohan, Sohel Daria, Abdullah Al Masud, Maizbha Uddin Ahmed, Arpita Roy, Mohammad Shahriar · 2023 · International Journal of Immunopathology and Pharmacology
50. The Innate Immune System and Inflammatory Priming: Potential Mechanistic Factors in Mood Disorders and Gulf War Illness
    Kyle J. Trageser, Maria Sebastian-Valverde, Sean X. Naughton, Giulio Maria Pasinetti · 2020 · Frontiers in Psychiatry
51. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
    Minghuan Zhu, Zhenjing Liu, Yanhong Guo, Sadia Sultana, Kang Wu, Xiaoe Lang, Qinyu Lv, Xiao Huang, Zhenghui Yi, Zezhi Li · 2021 · Journal of Neuroinflammation
52. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
    Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, Michael Berk, Wolfgang Marx, Andre Ferrer Carvalho, Chiara C. Bortolasci, Michael H. J. Maes, Basant K. Puri · 2022 · Molecular Neurobiology
53. Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum Disorders
    Halide Bilge Türközer, Paulo L. Lizano, Iniya K. Adhan, Elena I. Ivleva, Olivia Lutz, Victor Zeng, Alexandria Zeng, Nicholas Raymond, Deepthi Bannai, Adam Lee et al. · 2022 · Biological Psychiatry
54. Evidence for a causal association between psoriasis and psychiatric disorders using a bidirectional Mendelian randomization analysis in up to 902,341 individuals
    Yujie Wang, Xinquan Wang, Xiaoyu Gu, Jie Pan, Zhen Ouyang, Wenrui Lin, Wu Zhu, Mi Wang, Juan Su · 2023 · Journal of Affective Disorders
55. Increased number of monocytes and plasma levels of MCP ‐1 and YKL ‐40 in first‐episode psychosis
    Funda Orhan, Lilly Schwieler, Helena Fatouros‐Bergman, Anna Malmqvist, Simon Červenka, Karin Collste, Lena Flyckt, Lars Farde, Carl M. Sellgren, Fredrik Piehl et al. · 2018 · Acta Psychiatrica Scandinavica
56. Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique
    Jairo Vinícius Pinto, Gayatri Saraf, Christian Frysch, Daniel Vigo, Kamyar Keramatian, Trisha Chakrabarty, Raymond Wing Moon Lam, Marcia Kauer‐Sant’Anna, Lakshmi N. Yatham · 2019 · The Canadian Journal of Psychiatry
57. Regional, cellular and species difference of two key neuroinflammatory genes implicated in schizophrenia
    Caitlin E. Murphy, Yuji Kondo, Adam K. Walker, Debora A. Rothmond, Mitsuyuki Matsumoto, Cynthia Shannon Weickert · 2020 · Brain Behavior and Immunity
58. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing?
    Zarrin Ansari, Sudhir Ramlal Pawar, Rajmohan Seetharaman · 2021 · Postgraduate Medicine
59. Dietary inflammatory index and depression risk in patients with chronic diseases and comorbidity
    Cheng Shi Jiang, Han Yin, Anbang Liu, Quanjun Liu, Huan Ma, Qingshan Geng · 2022 · Journal of Affective Disorders
60. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis
    Jennifer K. Melbourne, Cherise Rosen, Benjamin Feiner, Rajiv P. Sharma · 2018 · Schizophrenia Research
61. Correction: Identifying and validating subtypes within major psychiatric disorders based on frontal–posterior functional imbalance via deep learning
    Miao Chang, Fay Y. Womer, Xiaohong Gong, Xi Chen, Lili Tang, Ruiqi Feng, Shuai Dong, Jia Duan, Yifan Chen, Ran Zhang et al. · 2020 · Molecular Psychiatry
62. Habituation of the biological response to repeated psychosocial stress: a systematic review and meta-analysis
    Barthel, Marie-Christin, Fricke, Kim, Muehlhan, Markus, Vogel, Susanne, Alexander, Nina · 2025 · Neuroscience & Biobehavioral Reviews
63. Microglia depletion ameliorates neuroinflammation, anxiety-like behavior, and cognitive deficits in a sex-specific manner in Rev-erbα knockout mice
    Ruizhuo Chen, Brandy N. Routh, Jillian E. Straetker, Cecily R. Gibson, Aidan S. Weitzner, Kiersten S. Bell, Andrew D. Gaudet, Laura K. Fonken · 2023 · Brain Behavior and Immunity
64. Inflammatory markers in persons with clinically-significant depression, anxiety or PTSD: A systematic review and meta-analysis
    J.K. Kuring, Jane L. Mathias, Lynn Ward, G. Tachas · 2023 · Journal of Psychiatric Research
65. Altered oral microbiota and immune dysfunction in Chinese elderly patients with schizophrenia: a cross-sectional study
    Zongxin Ling, Yiwen Cheng, Xia Liu, Xiumei Yan, Lingbin Wu, Li Shao, Jie Gao, Wenhui Lei, Qinghai Song, Na Zhao et al. · 2023 · Translational Psychiatry
66. Neuroimmune Biomarkers in Mental Illness
    James W. Herron, Louis Nerurkar, Jonathan Cavanagh · 2018 · Current topics in behavioral neurosciences
67. A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes
    Judit Lazáry, Nóra Eszlári, Gabriella Juhász, György Bagdy · 2019 · Journal of Affective Disorders
68. Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls
    Helen Q. Cai, Thomas Wesley Weickert, Vibeke Sorensen Catts, Ryan P. Balzan, Cherrie Ann Galletly, Dennis Liu, Maryanne O׳Donnell, Cynthia Shannon Weickert · 2020 · Brain Behavior and Immunity
69. Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression
    Xiaoyun Guo, Yanxia Rao, Ruizhi Mao, Lvchun Cui, Yiru Fang · 2020 · Neuropharmacology
70. Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction
    Ricarda Breitmeyer, Sabrina Vogel, Johanna Heider, Sophia-Marie Hartmann, Richard Wüst, Anna‐Lena Keller, Anna Binner, Julia Catherine Fitzgerald, Andreas Jochen Fallgatter, Hansjürgen Volkmer · 2023 · Communications Biology
71. Neutrophil/high-density lipoprotein cholesterol (HDL), monocyte/HDL and platelet/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors
    Korkmaz, Şükrü Alperen, Kızgın, Sadice · 2023 · Current Medical Research and Opinion
72. Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
    Katrien Skorobogatov, Valérie Autier, Marianne Foiselle, Jean‐Romain Richard, Wahid Boukouaci, Ching‐Lien Wu, Sophie Raynal, Christel Carbonne, Kris Laukens, Pieter Meysman et al. · 2023 · Brain Behavior & Immunity - Health
73. Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
    Song Chen, Yunlong Tan, Li Tian · 2024 · Molecular Psychiatry
74. State-dependent alterations of lipid profiles in patients with bipolar disorder
    Yu‐Jui Huang, Shang‐Ying Tsai, Kuo‐Hsuan Chung, Pao‐Huan Chen, Shou‐Hung Huang, Chian‐Jue Kuo · 2017 · The International Journal of Psychiatry in Medicine
75. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia
    Yezhe Lin, Yanmin Peng, Shen He, Jinjie Xu, Yuan Shi, Yousong Su, Cuizhen Zhu, Xinyi Zhang, Rubai Zhou, Donghong Cui · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
76. Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study
    Nils Kappelmann, Golam Mohammed Khandaker, Henrik Dal, Jan Štochl, Kyriaki Kosidou, Peter Brian Jones, Christina Dalman, Håkan Karlsson · 2018 · Psychological Medicine
77. Cross-genetic determination of maternal and neonatal immune mediators during pregnancy
    Michela Traglia, Lisa Croen, Karen L. Jones, Luke S. Heuer, Robert H. Yolken, Martin Kharrazi, Gerald N. DeLorenze, Paul Ashwood, Judy Van de Water, Lauren A. Weiss · 2018 · Genome Medicine
78. Traumagenics: At the intersect of childhood trauma, immunity and psychosis
    Kayla A. Chase, Jennifer K. Melbourne, Cherise Rosen, Simon McCarthy‐Jones, Nev Jones, Benjamin M. Feiner, Rajiv P. Sharma · 2018 · Psychiatry Research
79. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment
    Rafael Ribeiro-Santos, Salvina Maria de Campos-Carli, Rodrigo Ferretjans, Andréa Teixeira‐Carvalho, Olindo Assis Martins‐Filho, Antônio Lúcio Teixeira, João Vinícius Salgado · 2019 · Nordic Journal of Psychiatry
80. Elevated Osteopontin and Interferon Gamma Serum Levels and Increased Neutrophil-to-Lymphocyte Ratio Are Associated With the Severity of Symptoms in Schizophrenia
    Márton Áron Kovács, Tamás Tényi, Réka Kugyelka, Lilla Prenek, Lidia Hau, Éva Erzsébet Magyar, Róbert Herold, Péter Balogh, Diána Simon · 2020 · Frontiers in Psychiatry
81. Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: Results from a sham-controlled study
    Stephan A. Goerigk, Eric Cretaz, Bernardo Sampaio-Júnior, Érica Leandro Marciano Vieira, Wagner F. Gattaz, Izio Klein, Beny Lafer, Antônio Lúcio Teixeira, Andre Ferrer Carvalho, Paulo A. Lotufo et al. · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
82. Inflammation is correlated with abnormal functional connectivity in unmedicated bipolar depression: an independent component analysis study of resting-state fMRI
    Guixian Tang, Pan Chen, Guanmao Chen, Shuming Zhong, Jiaying Gong, Hui Zhong, Tao Ye, Feng Chen, Jurong Wang, Zhenye Luo et al. · 2021 · Psychological Medicine
83. Basal myokine levels are associated with quality of life and depressed mood in older adults
    Patrick Mucher, Delgerdalai Batmyagmar, Thomas Perkmann, Manuela Repl, Astrid Radakovics, Elisabeth Ponocny‐Seliger, Ina Lukas, Monika Fritzer‐Szekeres, Johann P. Lehrner, Thomas Knogler et al. · 2021 · Psychophysiology
84. Inflammatory cytokines and alcohol use disorder: systematic review and meta-analysis
    Helena Ferreira Moura, Fernanda Hansen, Fabiana Galland, Daiane Silvello, Fernando Pezzini Rebelatto, Felipe Rech Ornell, Raffael Massuda, Juliana Nichterwitz Scherer, Felipe Barreto Schuch, Félix Henrique Paim Kessler et al. · 2022 · Brazilian Journal of Psychiatry
85. Comparison of LPS and MS-induced depressive mouse model: behavior, inflammation and biochemical changes
    Xiaojin Yu, Hui Yao, Xiaohui Zhang, Lulu Liu, Shuangmei Liu, Youjing Dong · 2022 · BMC Psychiatry
86. Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients
    Susanne Bejerot, Sofia Sigra, Elisabet Welin Henriksson, Daniel Eklund, Ulrika Hylén, Mats B. Humble · 2022 · Journal of Psychiatric Research
87. Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study
    Brian J. Miller, P.F. Buckley, Joseph P. McEvoy · 2017 · Schizophrenia Research
88. Cocaine self‐administration is increased after frontal traumatic brain injury and associated with neuroinflammation
    Cole Vonder Haar, Jacqueline‐Marie N. Ferland, Sukhbir Kaur, Lara‐Kirstie Riparip, Susanna Rosi, Catharine A. Winstanley · 2018 · European Journal of Neuroscience
89. Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model
    Xingying Wu, Bowen Chen, Zhong Di, Shuo Jiang, Haipeng Xu, Mengting Shi, Rong Hu, Shaopeng Sun, Zhujin Song, Jiapeng Liu et al. · 2022 · BMC Neuroscience
90. The mind–skin connection: A narrative review exploring the link between inflammatory skin diseases and psychological stress
    G. Biazus Soares, Omar Mahmoud, Gil Yosipovitch, Hideki Mochizuki · 2024 · Journal of the European Academy of Dermatology and Venereology
91. Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review)
    Aspasia Manta, Anastasia Georganta, Afroditi Roumpou, Vassilis Zoumpourlis, Demetrios A. Spandidos, Emmanouil N. Rizos, Μelpomeni Peppa · 2025 · Molecular Medicine Reports
92. Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior
    Elisabeth Good Vichaya, Phillip S. Gross, Darlene J. Estrada, Steve W. Cole, Aaron J. Grossberg, Scott E. Evans, Michael J. Tuvim, Burton F. Dickey, Robert Dantzer · 2019 · Psychopharmacology
93. Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming
    Mandakh Bekhbat, David R. Goldsmith, Bobbi J. Woolwine, Ebrahim Haroon, Andrew H. Miller, Jennifer C. Felger · 2021 · Molecular Psychiatry
94. Effect of tetrahedral DNA nanostructures on LPS‐induced neuroinflammation in mice
    Xiao Yang, Fan Zhang, Yue Du, Weitong Cui, Yikai Dou, Yunfeng Lin, Zhihe Zhao, Xiaohong Ma · 2021 · Chinese Chemical Letters
95. Childhood trauma and the plasma levels of IL-6, TNF-α are risk factors for major depressive disorder and schizophrenia in adolescents: A cross-sectional and case-control study
    Yi Li, Jinxiang Tang, Yang Shu, Yadong Peng, Ying Liu, Yuan Meng, Zhang Ping, Hou Xiao, FU Yixiao · 2022 · Journal of Affective Disorders
96. Neuroinflammatory Biomarkers in Cerebrospinal Fluid From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
    Nina Vindegaard Sørensen, Sonja Orlovska‐Waast, Rose Jeppesen, Amalie Wandel Klein‐Petersen, Rune Haubo Bojesen Christensen, Michael E. Benros · 2022 · Biological Psychiatry
97. An inflamed subtype of difficult-to-treat depression
    Klara Suneson, Cécile Grudet, Filip Ventorp, Johan Malm, Marie Asp, Åsa Westrin, Daniel Lindqvist · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
98. Immune Cell Alterations in Psychotic Disorders: A Comprehensive Systematic Review and Meta-Analysis
    Max Clausen, Rune Haubo Bojesen Christensen, Maria Da Re, Michael E. Benros · 2024 · Biological Psychiatry
99. Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients
    Li Wei, Yupeng Du, Wei Wu, Xuyan Fu, Qi Xia · 2017 · Journal of Affective Disorders
100. An Update on Promising Biomarkers in Schizophrenia
     David R. Goldsmith, Courtney L. Crooks, Elaine F. Walker, Robert O. Cotes · 2018 · FOCUS The Journal of Lifelong Learning in Psychiatry